In this double-blind , randomized , placebo-controlled clinical trial , we evaluated systemic and mucosal immune responses to a candidate adenovirus serotype @ ( Ad@ ) vectored HIV-@ envelop ( Env ) vaccine in baseline Ad@-seronegative and Ad@-seropositive healthy volunteers .